The S&P/ASX 200 Index (ASX: XJO) has followed Wall Street's lead and dropped deep into the red. In afternoon trade, the benchmark index is down 1.4% to 8,628.5 points.
Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:
Domino's Pizza Enterprises Ltd (ASX: DMP)
The Domino's Pizza share price is up almost 2% to $21.84. This morning, the team at Citi upgraded the pizza chain operator's shares to a neutral rating (from sell) with an improved price target of $19.85 (from $13.25). Elsewhere, analysts at UBS have responded to the company's annual general meeting presentation positively. This has seen the broker retain its buy rating and lift its price target to $21.50.
DroneShield Ltd (ASX: DRO)
The DroneShield share price is up 4% to $2.34. Investors have been buying this counter drone technology company's shares on Friday following a massive 30% decline on Thursday due to insider selling. Bell Potter is likely to see this as a buying opportunity. It currently has a buy rating and $5.30 price target on its shares. It said: "We believe DRO has the market leading counter-drone offering and a strengthening competitive advantage owing to its years of experience and large R&D team, focused on detect and defeat capabilities. We expect 2026 will be an inflection point for the global counter-drone industry with countries poised to unleash a wave of spending on soft-kill detect and defeat solutions. Consequently, we believe DRO should see material contracts flowing from its $2,550m potential sales pipeline over the next 3-6 months as defence budgets roll over to FY26."
EBR Systems Inc (ASX: EBR)
The EBR Systems share price is up almost 2% to $1.16. This may have been driven by a broker note out of Bell Potter. Its analysts have retained its buy rating on the medical device company's shares with an improved price target of $2.43. It said: "Implants per trained Physician increased c.71% in 3Q25, showing that even in these early periods, utilisation is growing. Given the higher ASP, EBR only need 8 implants in 4Q25 to achieve our FY25 revenue estimate, where in fact implant numbers and Physician utilisation should grow qoq. For these reasons we believe consensus revenue estimates of c.US$15.7m in FY26 are low and expect upgrades to follow."
Lendlease Group (ASX: LLC)
The Lendlease share price is up 1% to $5.48. This follows the release of the property developer's annual general meeting update this morning. At the event, management commented: "Looking ahead for FY26, we continue to position the Group for profitable growth across our core operating segments and to strengthen the Group's balance sheet through asset sales and further deleveraging, noting $2 billion of C-R-U asset recycling targeted by the end of FY26."
